These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. IgG subclasses in human hydatid disease: prominence of the IgG4 response. Aceti A; Pennica A; Teggi A; Fondacaro LM; Caferro M; Leri O; Tacchi G; Celestino D; Quaranta G; De Rosa F Int Arch Allergy Immunol; 1993; 102(4):347-51. PubMed ID: 8241797 [TBL] [Abstract][Full Text] [Related]
63. Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis. van Twillert I; Bonačić Marinović AA; Kuipers B; van Gaans-van den Brink JA; Sanders EA; van Els CA Sci Rep; 2017 Jan; 7():40328. PubMed ID: 28091579 [TBL] [Abstract][Full Text] [Related]
64. Pertussis serosurveillance study in Izmir, Turkey. Türkoglu E; Sönmez C; Kurugöl Z; Çöplü N; Koturoğlu G J Trop Pediatr; 2015 Feb; 61(1):32-6. PubMed ID: 25424662 [TBL] [Abstract][Full Text] [Related]
65. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126 [TBL] [Abstract][Full Text] [Related]
66. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R; Lønnes T; Møgster B; Berdal BP Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124 [TBL] [Abstract][Full Text] [Related]
67. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. Tuomanen EI; Zapiain LA; Galvan P; Hewlett EL J Clin Microbiol; 1984 Aug; 20(2):167-70. PubMed ID: 6092416 [TBL] [Abstract][Full Text] [Related]
68. Rapid detection of IgG subclasses on DAT positive RBC membranes by flow cytometry (FC). Asmussen C; Gutensohn K; Wittkopf D; Kühnl P Beitr Infusionsther Transfusionsmed; 1996; 33():35-9. PubMed ID: 8865935 [TBL] [Abstract][Full Text] [Related]
69. Absence of antibodies against Bordetella pertussis in pregnant women and newborns in the state of Nuevo Leon. Villarreal-Pérez JZ; Ramírez-Aranda JM; Rodríguez-Rodríguez I; Perales-Dávila J; García-Elizondo FJ; Gómez-Gómez C; Galindo-Galindo E; Rodríguez-Moreno MA; Ballesteros-Elizondo R J Perinat Med; 2014 Sep; 42(5):649-54. PubMed ID: 24572974 [TBL] [Abstract][Full Text] [Related]
70. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults. Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342 [TBL] [Abstract][Full Text] [Related]
71. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka. Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894 [TBL] [Abstract][Full Text] [Related]
72. Evaluation of host humoral antibody production against Plasmodium falciparum recombinant circumsporozoite antigen in Nigerian children. Oluwasogo OA; Ebenezer OO; Chiaka A J Vector Borne Dis; 2012 Sep; 49(3):151-6. PubMed ID: 23135009 [TBL] [Abstract][Full Text] [Related]
73. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population. Lau RC N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227 [TBL] [Abstract][Full Text] [Related]
74. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190 [TBL] [Abstract][Full Text] [Related]
75. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763 [TBL] [Abstract][Full Text] [Related]
76. Serological responses to infection with B. pertussis. Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353 [TBL] [Abstract][Full Text] [Related]
77. [Humoral imunity to pertussis in children with diabetes of type 1]. Tarasova AA; Kostinov MP; Zaĭtsev EM Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):53-7. PubMed ID: 16830591 [TBL] [Abstract][Full Text] [Related]
78. Comparison of in-house enzyme-linked immunosorbent assay (ELISA) and six commercial ELISAs for Detection of antibodies to Bordetella pertussis. Rastawicki W J Microbiol Methods; 2024 Sep; 224():107011. PubMed ID: 39111714 [TBL] [Abstract][Full Text] [Related]
79. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy. Hussain R; Dockrell HM; Chiang TJ Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976 [TBL] [Abstract][Full Text] [Related]
80. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]